Latest Articles
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer - OncLive
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer OncLive
Published: Jan. 26, 2024, 8 a.m.
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer - Nature.com
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer Nature.com
Published: Jan. 17, 2024, 8 a.m.
A substantial step toward earlier endometrial cancer detection - Mayo Clinic
A substantial step toward earlier endometrial cancer detection Mayo Clinic
Published: Jan. 9, 2024, 8 a.m.
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis - Nature.com
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis Nature.com
Published: Jan. 8, 2024, 8 a.m.
TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway - Nature.com
TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway Nature.com
Published: Jan. 3, 2024, 8 a.m.
Link copied to clipboard!